The legacy success of sildenafil has undeniably influenced the healthcare landscape. However, investing in companies heavily dependent on biosimilars and the declining patent protection surrounding this https://e-bookmarks.com/story7130698/the-blue-pill-and-pharma-a-uncertain-venture